{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:01:44Z","timestamp":1780704104010,"version":"3.54.1"},"reference-count":45,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100004686","name":"King Faisal University, Kingdom of Saudi Arabia","doi-asserted-by":"publisher","award":["170077"],"award-info":[{"award-number":["170077"]}],"id":[{"id":"10.13039\/501100004686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2019,4,12]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Benzothiazole derivatives are known for anti-TB properties. Based on the\nknown anti-TB benzothiazole pharmacophore, in the present study, we described the synthesis,\nstructural elucidation, and anti-tubercular screening of a series of novel benzothiazole (BNTZ) derivatives\n(BNTZ 1\u20137 and BNTZ 8\u201313).<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p> The study aims to carry out the development of benzothiazole based anti-TB compounds.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> Title compounds are synthesized by microwave method and purified by column chromatography.\nCharacterization of the compounds is achieved by FT-IR, NMR (1H and 13C), LCMS\nand elemental analysis. Screening of test compounds for anti-TB activity is achieved by Resazurin\nMicroplate Assay (REMA) Plate method.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> It was noted that the BNTZ compound with an isoquinoline nucleus (BNTZ 9) exhibited\nremarkable anti-tubercular activity at 8 &amp;\u00b5g\/mL against both the susceptible strain H37Rv and the\nmulti-drug resistant tuberculosis strains of Mycobacterium tuberculosis. On the other hand, the\nBNTZ compound with a naphthalene nucleus (BNTZ 2) revealed anti-tubercular activity at 6\n\u00b5g\/mL and 11 &amp;\u00b5g\/mL against both the susceptible strain H37Rv and the multi-drug resistant tuberculosis\nstrains of M. tuberculosis, respectively. One of the selected BNTZ derivatives BNTZ 13\nwas used for single crystal X-ray studies.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> To identify the appropriate target for potent BNTZ compounds from the series, molecular\nmodeling studies revealed the multiple strong binding of several BNTZs with mycobacterium\nlysine-\u025b-aminotransferase and decaprenyl-phosphoryl-\u03b2-D-ribose 2&amp;'-oxidase. The interaction\nis derived by forming favorable hydrogen bonds and stacking interactions. This new class of\nBNTZ compounds gave promising anti-tubercular actions in the low micromolar range, and can be\nfurther optimized on a structural basis to develop promising, novel, BNTZ pharmacophore-based\nanti-tubercular drugs.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1573406414666180703121815","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T02:32:17Z","timestamp":1536633137000},"page":"311-326","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification"],"prefix":"10.2174","volume":"15","author":[{"given":"Katharigatta N.","family":"Venugopala","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Chandrashekharappa","sequence":"additional","affiliation":[{"name":"Institute for Stem Cell Biology and Regenerative Medicine, NCBS, TIFR, GKVK, Bellary Road, Bangalore 560 065, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melendhran","family":"Pillay","sequence":"additional","affiliation":[{"name":"Department of Microbiology, National Health Laboratory Services, KZN Academic Complex, Inkosi Albert Luthuli Central Hospital, Durban 4001, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhrajyoti","family":"Bhandary","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Indian Institute of Science Education and Research Bhopal, Bhopal By-pass Road, Bhauri, Bhopal 462 066, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Kandeel","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh 33511, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawzi M.","family":"Mahomoodally","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Faculty of Science, University of Mauritius, Reduit, Mauritius"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Morsy","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Chopra","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Indian Institute of Science Education and Research Bhopal, Bhopal By-pass Road, Bhauri, Bhopal 462 066, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandar E.","family":"Aldhubiab","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Attimarad","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama I.","family":"Alwassil","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sree","family":"Harsha","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koleka","family":"Mlisana","sequence":"additional","affiliation":[{"name":"Department of Microbiology, National Health Laboratory Services, KZN Academic Complex, Inkosi Albert Luthuli Central Hospital, Durban 4001, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharti","family":"Odhav","sequence":"additional","affiliation":[{"name":"Department of Biotechnology and Food Technology, Durban University of Technology, Durban 4001, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","author":"","year":"","unstructured":"WHO, WHO Global Tuberculosis Report.http:\/\/www.who.int\/tb\/publications\/global_report\/en\/ visited on\nDecember 25, 2017, 1-249."},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1472-9792(02)00058-6","volume":"83","author":"Marcos A.E.","year":"2003","unstructured":"Marcos AE.  The global situation of MDR-TB.","journal-title":"Tuberc"},{"key":"ref=3","first-page":"621","volume":"10","author":"Caminero J.A.","year":"2010","unstructured":"Caminero JA, Sotgiu G, Zumla A, Migliori GB.  Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis.","journal-title":"Dis"},{"key":"ref=4","first-page":"4563826","volume":"2017","author":"Hu Y.","year":"2017","unstructured":"Hu Y, Xu L, He YL, Pang Y, Lu N, Liu J, Shen J, Zhu DM, Feng X, Wang YW, Yang C.  Prevalence and molecular characterization of second-line drugs resistance among multidrug-resistant Mycobacterium tuberculosis isolates in southwest of China.","journal-title":"BioMed Res Int"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/joim.12264","volume":"277","author":"Parida S.K.","year":"2015","unstructured":"Parida SK, Axelsson-Robertson R, Rao MV, Singh N, Master I, Lutckii A, Keshavjee S, Andersson J, Zumla A, Maeurer M.  Totally drug-resistant tuberculosis and adjunct therapies.","journal-title":"J Intern Med"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMp1314385","volume":"371","author":"Cox E.","year":"2014","unstructured":"Cox E, Laessig K.  FDA approval of bedaquiline - the benefit\u2013risk balance for drug-resistant Tuberculosis.","journal-title":"N Engl J Med"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.3823","volume":"21","author":"Barry Iii C.E.","year":"2015","unstructured":"Barry Iii CE.  Timing is everything for compassionate use of delamanid.","journal-title":"Nat Med"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejmech.2013.04.061","volume":"65","author":"Venugopala K.N.","year":"2013","unstructured":"Venugopala KN, Krishnappa M, Nayak SK, Subrahmanya BK, Vaderapura JP, Chalannavar RK, Gleiser RM, Odhav B.  Synthesis and antimosquito properties of 2,6-substituted benzo[d]thiazole and 2,4-substituted benzo[d]thiazole analogues against Anopheles arabiensis.","journal-title":"Eur J Med Chem"},{"key":"ref=9","first-page":"63","volume":"62","author":"Rida S.M.","year":"2012","unstructured":"Rida SM, Youssef AM, Badr MH, Malki A, Sherif ZA, Sultan AS.  Design, synthesis and evaluation of novel benzimidazoles, benzothiazoles and benzofurans incorporating pyrazole moiety as antiangiogenic agents.","journal-title":"Arzneim"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1007\/s00044-015-1358-0","volume":"24","author":"Shaikh F.M.","year":"2015","unstructured":"Shaikh FM, Patel NB, Sanna G, Busonera B, Colla P, Rajani DP.  Synthesis of some new 2-amino-6-thiocyanato benzothiazole derivatives bearing 2,4-thiazolidinediones and screening of their  antimicrobial, antitubercular and antiviral activities.","journal-title":"Med Chem Res"},{"key":"ref=11","first-page":"1062","volume":"52","author":"Singh M.","year":"2014","unstructured":"Singh M, Gangwar M, Nath G, Singh SK.  Synthesis, DNA cleavage and antimicrobial activity of 4-thiazolidinones-benzothiazole conjugates. Ind.","journal-title":"J Exp Biol"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1515\/znb-1981-0122","volume":"36B","author":"Abuzar S.","year":"1981","unstructured":"Abuzar S, Sharma S.  Synthesis of 6-N-aryl and heteroaryl benzthiazoles as potential anthelmintics.","journal-title":"Z Naturforsch"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00044-016-1520-3","volume":"25","author":"Puranik N.V.","year":"2016","unstructured":"Puranik NV, Puntambekar HM, Srivastava P.  Antidiabetic potential and enzyme kinetics of benzothiazole derivatives and their non-bonded interactions with \u03b1-glucosidase and \u03b1-amylase.","journal-title":"Med Chem Res"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.3390\/molecules20057775","volume":"20","author":"Nagoshi N.","year":"2015","unstructured":"Nagoshi N, Nakashima H, Fehlings MG.  Riluzole as a neuroprotective drug for spinal cord injury: from bench to bedside.","journal-title":"Molecules"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1039\/c1md00129a","volume":"2","author":"Shah F.","year":"2011","unstructured":"Shah F, Wu Y, Gut J, Pedduri Y, Legac J, Rosenthal PJ, Avery MA.  Design, synthesis and biological evaluation of novel benzothiazole and triazole analogs as falcipain inhibitors.","journal-title":"MedChemComm"},{"key":"ref=16","author":"Valcke A.R.A.","year":"1998","unstructured":"Valcke ARA, Van Der Flaas MAJ."},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/j.bmc.2017.03.053","volume":"25","author":"Reshma R.S.","year":"2017","unstructured":"Reshma RS, Jeankumar VU, Kapoor N, Saxena S, Bobesh KA, Vachaspathy AR, Kolattukudy PE, Sriram D.  Mycobacterium tuberculosis lysine-varepsilon-aminotransferase a potential target in dormancy: Benzothiazole based inhibitors.","journal-title":"Bioorg Med Chem"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejmech.2015.04.011","volume":"96","author":"Chikhale R.","year":"2015","unstructured":"Chikhale R, Menghani S, Babu R, Bansode R, Bhargavi G, Karodia N, Rajasekharan MV, Paradkar A, Khedekar P.  Development of selective DprE1 inhibitors: Design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides.","journal-title":"Eur J Med Chem"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"7694","DOI":"10.1016\/j.bmc.2015.11.017","volume":"23","author":"Landge S.","year":"2015","unstructured":"Landge S, Mullick AB, Nagalapur K, Neres J, Subbulakshmi V, Murugan K, Ghosh A, Sadler C, Fellows MD, Humnabadkar V, Mahadevaswamy J, Vachaspati P, Sharma S, Kaur P, Mallya M, Rudrapatna S, Awasthy D, Sambandamurthy VK, Pojer F, Cole ST, Balganesh TS, Ugarkar BG, Balasubramanian V, Bandodkar BS, Panda M, Ramachandran V.  Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-beta-D-ribose 2\u2032-oxidase.","journal-title":"Med Chem"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1021\/acs.jcim.6b00056","volume":"56","author":"Mehra R.","year":"2016","unstructured":"Mehra R, Rajput VS, Gupta M, Chib R, Kumar A, Wazir P, Khan IA, Nargotra A.  Benzothiazole derivative as a novel Mycobacterium tuberculosis Shikimate kinase inhibitor: Identification and elucidation of its allosteric mode of inhibition.","journal-title":"J Chem Inf Model"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/psc.1389","volume":"17","author":"Venugopala K.N.","year":"2011","unstructured":"Venugopala KN, Albericio F, Coovadia YM, Kruger HG, Maguire GEM, Pillay M, Govender T.  Total synthesis of a depsidomycin analogue by convergent solid-phase peptide synthesis and macrolactonization strategy for antitubercular activity.","journal-title":"J Pept Sci"},{"key":"ref=22","first-page":"219","volume":"81","author":"Venugopala K.N.","year":"2013","unstructured":"Venugopala KN, Nayak SK, Pillay M, Prasanna R, Coovadia YM, Odhav B.  Synthesis and antitubercular activity of 2-(substituted phenyl\/benzyl-amino)-6-(4-chlorophenyl)-5-(met-hoxycarbonyl)-4-methyl-3,6-dihydropyrimidin-1-ium chlorides.","journal-title":"Des"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.2147\/DDDT.S109760","volume":"10","author":"Venugopala K.N.","year":"2016","unstructured":"Venugopala KN, Dharma RGB, Bhandary S, Pillay M, Chopra D, Aldhubiab BE, Attimarad M, Alwassil OI, Harsha S, Mlisana K.  Design, synthesis, and characterization of (1-(4-aryl)-1H-1,2,3-triazol-4-yl) methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis.","journal-title":"Drug Des Devel Ther"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1080\/07391102.2017.1345325","volume":"36","author":"Khedr M.A.","year":"2018","unstructured":"Khedr MA, Pillay M, Chandrashekharappa S, Chopra D, Aldhubiab BE, Attimarad M, Alwassil OI, Mlisana K, Odhav B, Venugopala KN.  Molecular modeling studies and anti-TB activity of trisubstituted indolizine analogues; molecular docking and dynamic inputs.","journal-title":"J Biomol Struct Dyn"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1021\/jm00285a022","volume":"14","author":"Palmer P.J.","year":"1971","unstructured":"Palmer PJ, Trigg RB, Warrington JV.  Benzothiazolines as antituberculous agents.","journal-title":"J Med Chem"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1107\/S2052520614006209","volume":"70","author":"Panini P.","year":"2014","unstructured":"Panini P, Venugopala KN, Odhav B, Chopra D.  Polymorphism in two biologically active dihydropyrimidinium hydrochloride derivatives: quantitative inputs towards the energetics associated with crystal packing.","journal-title":"Acta Crystallogr B Struct Sci CrystSect B Eng Mater"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s40010-014-0143-7","volume":"84","author":"Panini P.","year":"2014","unstructured":"Panini P, Venugopala KN, Odhav B, Chopra D.  Quantitative analysis of intermolecular interactions in 7-hydroxy-4-methyl-2H-chromen-2-one and its hydrate.","journal-title":"P Natl A Sci India A"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1021\/cg049948l","volume":"4","author":"Munshi P.","year":"2004","unstructured":"Munshi P, Venugopala KN, Jayashree BS, Guru RTN.  Concomitant polymorphism in 3-acetylcoumarin:\u2009Role of weak C\u2212H\u00b7\u00b7\u00b7O and C\u2212H\u00b7\u00b7\u00b7\u03c0 interactions.","journal-title":"Cryst Growth Des"},{"key":"ref=29","author":"Siemens S.S.","year":"1995","unstructured":"Siemens SS.","journal-title":"Siemens Analytical X-ray Instruments Inc"},{"key":"ref=30","author":"","year":"2006","unstructured":".","journal-title":"Apex2, Version 2 User Manual M86-E01078"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1107\/S1600576715001132","volume":"48","author":"Burla M.C.","year":"2015","unstructured":"Burla MC, Caliandro R, Carrozzini B, Cascarano GL, Cuocci C, Giacovazzo C, Mallamo M, Mazzone A, Polidori G.  Crystal structure determination and refinement  SIR2014.","journal-title":"J Appl Cryst"},{"key":"ref=32","first-page":"3","volume":"71","author":"Sheldrick G.","year":"2015","unstructured":"Sheldrick G.  A short history of SHELX.","journal-title":"Sec C"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1107\/S0021889899006020","volume":"32","author":"Farrugia L.","year":"1999","unstructured":"Farrugia L.  WinGX suite for small-molecule single-crystal crystallography.","journal-title":"J Appl Cryst"},{"key":"ref=34","author":"Sheldrick G.M.","year":"1997","unstructured":"Sheldrick GM.","journal-title":"SHELXS-97, SHELXL-2014 and SADABS version 205"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1107\/S0021889807067908","volume":"41","author":"Macrae C.F.","year":"2008","unstructured":"Macrae CF, Bruno IJ, Chisholm JA, Edgington PR, McCabe P, Pidcock E, Rodriguez-Monge L, Taylor R, van de Streek J, Wood PA.  Mercury CSD 2.0 - new features for the visualization and investigation of crystal structures.","journal-title":"J Appl Cryst"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1107\/S0021889895007138","volume":"28","author":"Nardelli M.","year":"1995","unstructured":"Nardelli M.  PARST95 - an update to PARST: a system of Fortran routines for calculating molecular structure parameters from the results of crystal structure analyses.","journal-title":"J Appl Cryst"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1107\/S0021889802022112","volume":"36","author":"Spek A.","year":"2003","unstructured":"Spek A.  Single-crystal structure validation with the program PLATON.","journal-title":"J Appl Cryst"},{"key":"ref=38","first-page":"901","volume":"9","author":"Martin A.","year":"2005","unstructured":"Martin A, Morcillo N, Lemus D, Montoro E, Telles MA, Simboli N, Pontino M, Porras T, Leon C, Velasco M, Chacon L, Barrera L, Ritacco V, Portaels F, Palomino JC.  Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs.","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"Friesner R.A.","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.","journal-title":"J Med Chem"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbrc.2015.05.055","volume":"463","author":"Tripathi S.M.","year":"2015","unstructured":"Tripathi SM, Agarwal A, Ramachandran R.  Mutational analysis of Mycobacterium tuberculosis lysine varepsilon-aminotransferase and inhibitor co-crystal structures, reveals distinct binding modes.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jmb.2006.08.019","volume":"362","author":"Tripathi S.M.","year":"2006","unstructured":"Tripathi SM, Ramachandran R.  Direct evidence for a glutamate switch necessary for substrate recognition: crystal structures of lysine \u03b5-aminotransferase (Rv3290c) from Mycobacterium tuberculosis H37Rv.","journal-title":"J Mol Biol"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"11354","DOI":"10.1073\/pnas.1205735109","volume":"109","author":"Batt S.M.","year":"2012","unstructured":"Batt SM, Jabeen T, Bhowruth V, Quill L, Lund PA, Eggeling L, Alderwick LJ, Futterer K, Besra GS.  Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"12366","DOI":"10.1021\/ja405853p","volume":"135","author":"Blanco B.","year":"2013","unstructured":"Blanco B, Prado V, Lence E, Otero JM, Garcia-Doval C, van Raaij MJ, Llamas-Saiz AL, Lamb H, Hawkins AR, Gonz\u00e1lez-Bello C.  Mycobacterium tuberculosis Shikimate kinase inhibitors: Design and simulation studies of the catalytic turnover.","journal-title":"J Am Chem Soc"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1248\/bpb.b17-00241","volume":"40","author":"Alnazawi M.","year":"2017","unstructured":"Alnazawi M, Altaher A, Kandeel M.  Comparative genomic analysis MERS CoV i\tsolated from humans and camels with special reference to virus encoded helicase.","journal-title":"Biol Pharm Bull"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10822-013-9665-3","volume":"27","author":"Kandeel M.","year":"2013","unstructured":"Kandeel M, Kitade Y.  In silico molecular docking analysis of the human Argonaute 2 PAZ domain reveals insights into RNA interference.","journal-title":"J Comput Aided Mol Des"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/163449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T23:36:47Z","timestamp":1569281807000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/163449\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,4,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406414666180703121815","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}